NCT00756444
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +9 more
- Locations
-
Not specified
Clinical trial condition
Carcinoma, Squamous Cell
Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.
1,631 public trials
442 recruiting studies
Carcinoma, Squamous Cell trial results
NCT00006471
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
NCT00004246
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
NCT01591135
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Fudan University Cancer Center Shanghai, Shanghai Municipality, China
NCT00675233
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +12 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01417936
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck, +6 more
- Locations
-
- 3203; Antwerp University Hospital; Department of Medical Oncology Antwerp, Edegem, Belgium
- 3202; Jules Bordet Institute; Clinique d'Oncologie Médicale Brussels, Belgium
- 3201; Cliniques Universitaires St-Luc; Centre du Cancer Brussels, Belgium
- 3303; Centre Alexis Vautrin; Département d'Oncologie Médicale Nancy, Vandoeuvre Les Nancy, France
Completed
Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00030576
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
- Locations
-
- Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
- Queen's University Kingston, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
- Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
Completed
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00055913
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +18 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
Completed
Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
NCT02350712
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +10 more
- Locations
-
- The Royal Marsden Hospital Sutton, Surrey, United Kingdom
- University College London Hospital London, United Kingdom
- The Royal Marsden Hospital London, United Kingdom
NCT01218048
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- UPCI - Hillman Cancer Center Pittsburgh, Pennsylvania, United States